1 completed, 1 not yet recruiting, 1 recruiting, 1 withdrawn. 4 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 4 | Completed 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1 |
Follow Personality Disorders: new trials by email Literature Review of Personality Disorders trials Research Report on Personality Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of Methylphenidate on Symptomatology in Individuals With Borderline Personality Disorder methylphenidate, matched placebo tablet - Borderline Personality Disorder | Early Phase 1 | Not yet recruiting | Tanta University | 60 | 2025-01-15 | 2025-01-06 |
| Light Therapy for Obsessive-compulsive Disorder (OCD) Light therapy - OCD | Early Phase 1 | Recruiting | Washington University School of Medicine | 40 | 2024-12-16 | 2026-08-18 |
| Role of Oxytocin in Telling and Detecting Lies Oxytocin - Dyssocial Behavior | Early Phase 1 | Withdrawn | University of Texas at Austin | 2016-01-01 | 2016-06-13 | |
| Exceptional Experiences (EE), Salience & Dopaminergic Neurotransmission 200 mg levodopa/50 mg benserazide, Dextrose - Healthy, Schizotypal Personality | Early Phase 1 | Completed | University of Zurich | 65 | 2014-05-15 | 2017-11-06 |
Antisocial Personality Disorder (1) · Borderline Personality Disorder (1) · Compulsive Personality Disorder (1) · Schizotypal Personality Disorder (1)
Mental Disorders (4)
Glucose (1) · Methylphenidate (1) · Oxytocin (1) · Phototherapy (1) · benserazide, levodopa drug combination (1)
Tanta University (1) · University of Texas at Austin (1) · University of Zurich (1) · Washington University School of Medicine (1)
Switzerland (1) · United States (1)
Rebecca Cox, PhD (1) · Robert A Josephs, PhD (1)